Published in Clin Exp Hypertens on February 10, 2005
Several common variants modulate heart rate, PR interval and QRS duration. Nat Genet (2010) 3.34
Association of resting heart rate with carotid and aortic arterial stiffness: multi-ethnic study of atherosclerosis. Hypertension (2013) 2.18
Stimulants and cardiovascular events in youth with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (2011) 1.80
Vav3 proto-oncogene deficiency leads to sympathetic hyperactivity and cardiovascular dysfunction. Nat Med (2006) 1.27
Discovery of common human genetic variants of GTP cyclohydrolase 1 (GCH1) governing nitric oxide, autonomic activity, and cardiovascular risk. J Clin Invest (2007) 1.25
Heart rate is associated with increased risk of major cardiovascular events, cardiovascular and all-cause death in patients with stable chronic cardiovascular disease: an analysis of ONTARGET/TRANSCEND. Clin Res Cardiol (2013) 1.16
Tachycardia, reduced vagal capacity, and age-dependent ventricular dysfunction arising from diminished expression of the presynaptic choline transporter. Am J Physiol Heart Circ Physiol (2010) 0.95
Physiological correlates of bereavement and the impact of bereavement interventions. Dialogues Clin Neurosci (2012) 0.95
Resting heart rate: a modifiable prognostic indicator of cardiovascular risk and outcomes? Can J Cardiol (2008) 0.88
Cardiac effects of muscarinic receptor antagonists used for voiding dysfunction. Br J Clin Pharmacol (2011) 0.87
Heart rate at hospital discharge in patients with heart failure is associated with mortality and rehospitalization. J Am Heart Assoc (2015) 0.85
Association of resting heart rate with cardiovascular function: a cross-sectional study in 522 Finnish subjects. BMC Cardiovasc Disord (2013) 0.84
Omega-3 polyunsaturated Fatty acids and heart rate variability. Front Physiol (2011) 0.83
Associations of age with serum insulin, proinsulin and the proinsulin-to-insulin ratio: a cross-sectional study. BMC Endocr Disord (2010) 0.82
Prognostic significance of heart rate in hospitalized patients presenting with myocardial infarction. World J Cardiol (2012) 0.81
Variation in resting heart rate over 4 years and the risks of myocardial infarction and death among older adults. Heart (2014) 0.80
Burnout Is Associated with Reduced Parasympathetic Activity and Reduced HPA Axis Responsiveness, Predominantly in Males. Biomed Res Int (2015) 0.79
Resting Heart Rate Is Not a Good Predictor of a Clustered Cardiovascular Risk Score in Adolescents: The HELENA Study. PLoS One (2015) 0.78
Heart rate before ICU discharge: a simple and readily available predictor of short- and long-term mortality from critical illness. Clin Res Cardiol (2013) 0.78
Prognostic value of resting heart rate on cardiovascular and renal outcomes in type 2 diabetic patients: a competing risk analysis in a prospective cohort. Diabetes Care (2012) 0.78
Hyperlipidemia Is Associated with Chronic Urticaria: A Population-Based Study. PLoS One (2016) 0.78
The effect of marine n-3 polyunsaturated fatty acids on cardiac autonomic and hemodynamic function in patients with psoriatic arthritis: a randomised, double-blind, placebo-controlled trial. Lipids Health Dis (2016) 0.77
Effects of aerobic exercise on the resting heart rate, physical fitness, and arterial stiffness of female patients with metabolic syndrome. J Phys Ther Sci (2016) 0.77
Human heart rate: heritability of resting and stress values in twin pairs, and influence of genetic variation in the adrenergic pathway at a microribonucleic acid (microrna) motif in the 3'-UTR of cytochrome b561 [corrected]. J Am Coll Cardiol (2013) 0.76
Racing to the flatline: heart rate and β-adrenergic stimulation quicken the pace. Am J Physiol Heart Circ Physiol (2015) 0.75
When heart goes "BOOM" to fast. Heart rate greater than 80 as mortality predictor in acute myocardial infarction. Am J Cardiovasc Dis (2013) 0.75
Resting Heart Rate Does Not Predict Cardiovascular and Renal Outcomes in Type 2 Diabetic Patients. J Diabetes Res (2015) 0.75
Heritability of heart rate recovery and vagal rebound after exercise. Eur J Appl Physiol (2016) 0.75
Resting sinus heart rate and first degree av block: modifiable risk predictors or epiphenomena? Indian Pacing Electrophysiol J (2009) 0.75
The Effect of CardioWaves Interval Training on Resting Blood Pressure, Resting Heart Rate, and Mind-Body Wellness. Int J Exerc Sci (2016) 0.75
Short-term effects of ivabradine in patients with chronic stable ischemic heart disease. Heart Views (2013) 0.75
Pulsatility Index as a Diagnostic Parameter of Reciprocating Wall Shear Stress Parameters in Physiological Pulsating Waveforms. PLoS One (2016) 0.75
The Role of Ivabradine in the Management of Angina Pectoris. Cardiovasc Drugs Ther (2016) 0.75
Heart rate and cardiovascular disease: an alternative to Beta blockers. Cardiol Res Pract (2009) 0.75
[ProCor: an extramural screening on heart rate reduction in patients with chronic stable angina pectoris in Austria]. Wien Klin Wochenschr (2010) 0.75
Elevated Long Term Resting Heart Rate Variation is Associated with Increased Risk of All-cause Mortality in Northern China. Sci Rep (2017) 0.75
Blood pressure crisis following withdrawal of clonidine (Catapres, Catapresan), with special reference to arterial and urinary catecholamine levels, and suggestions for acute management. Am Heart J (1973) 2.17
Home blood pressure determination. Value in borderline ("labile") hypertension. JAMA (1974) 2.16
The 1993 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. Blood Press (1993) 2.03
Reference values for self-recorded blood pressure: a meta-analysis of summary data. Arch Intern Med (1998) 2.01
Home blood pressure monitoring. Arch Intern Med (2000) 1.71
High heart rate: a risk factor for cardiovascular death in elderly men. Arch Intern Med (1999) 1.62
Type II diabetes, essential hypertension, and obesity as "syndromes of impaired genetic homeostasis": the "thrifty genotype" hypothesis enters the 21st century. Perspect Biol Med (1998) 1.57
Heart rate and the cardiovascular risk. J Hypertens (1997) 1.57
Are left ventricular mass, geometry and function related to vascular changes and/or insulin resistance in long-standing hypertension? ICARUS: a LIFE substudy. J Hum Hypertens (2003) 1.51
Reflex sympathetic activation induces acute insulin resistance in the human forearm. Hypertension (1993) 1.48
Lead, hypertension, and the renin-angiotensin system in rats. J Lab Clin Med (1982) 1.45
Predictors of new-onset diabetes mellitus in hypertensive patients: the VALUE trial. J Hum Hypertens (2008) 1.44
Diagnostic significance of abdominal murmurs. N Engl J Med (1967) 1.29
The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study Group. Am J Hypertens (1997) 1.28
Hemodynamic effects of acute and prolonged beta-adrenergic blockade in essential hypertension. Acta Med Scand (1974) 1.28
Relationship between cardiac output and peripheral resistance in borderline hypertension. Circulation (1971) 1.23
Influence of age on the hemodynamic response to exercise. Circulation (1967) 1.22
Relationship of tachycardia with high blood pressure and metabolic abnormalities: a study with mixture analysis in three populations. Hypertension (1997) 1.22
Mild high-renin essential hypertension. Neurogenic human hypertension? N Engl J Med (1977) 1.18
Role of parasympathetic inhibition in the hyperkinetic type of borderline hypertension. Circulation (1971) 1.15
Hemodynamic studies in patients with borderline blood pressure elevation. Circulation (1968) 1.11
Hemodynamic responses to tilt and beta-adrenergic blockade in young patients with borderline hypertension. Circulation (1970) 1.10
Sex-specific determinants of increased left ventricular mass in the Tecumseh Blood Pressure Study. Circulation (1994) 1.10
Relationship of the electrocardiographic strain pattern to left ventricular structure and function in hypertensive patients: the LIFE study. Losartan Intervention For End point. J Am Coll Cardiol (2001) 1.10
Relationships between metrics of visit-to-visit variability of blood pressure. J Hum Hypertens (2013) 1.08
Easy money? Health cost savings resulting from the switch from a branded drug to a low-cost generic drug in the same class. Int J Clin Pract (2011) 1.07
Baseline characteristics in relation to electrocardiographic left ventricular hypertrophy in hypertensive patients: the Losartan intervention for endpoint reduction (LIFE) in hypertension study. The Life Study Investigators. Hypertension (2000) 1.07
Association of tachycardia with morbidity and mortality: pathophysiological considerations. J Hum Hypertens (1997) 1.06
Effect of beta-adrenergic blockade on plasma volume in human subjects. Proc Soc Exp Biol Med (1972) 1.03
The international database of self-recorded blood pressures in normotensive and untreated hypertensive subjects. Blood Press Monit (1999) 1.03
Autonomic imbalance, hypertension, and cardiovascular risk. Am J Hypertens (2000) 1.02
Mechanism of increased alpha adrenergic vasoconstriction in human essential hypertension. J Clin Invest (1987) 1.02
Effect of beta adrenoceptor antagonists on baroreceptor reflex sensitivity in hypertension. Clin Pharmacol Ther (1977) 1.01
Autonomic nervous cardiovascular regulation in borderline hypertension. Am J Cardiol (1975) 1.01
Borderline hypertension--a critical review. J Chronic Dis (1971) 1.00
Angiotensin mediates forearm glucose uptake by hemodynamic rather than direct effects. Hypertension (1996) 1.00
Relation of echocardiographic left ventricular mass and hypertrophy to persistent electrocardiographic left ventricular hypertrophy in hypertensive patients: the LIFE Study. Am J Hypertens (2001) 0.99
Characteristics of 9194 patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint Reduction in Hypertension. Hypertension (1998) 0.99
Influence of hypertension on the hemodynamic response to exercise. Circulation (1967) 0.97
Racial differences in erythrocyte cation transport. Hypertension (1984) 0.93
The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial of cardiovascular events in hypertension. Rationale and design. Blood Press (1998) 0.92
Effect of home blood pressure and gender on estimates of the familial aggregation of blood pressure. The Tecumseh Blood Pressure Study. Hypertension (1992) 0.92
The effect of baseline physical activity on cardiovascular outcomes and new-onset diabetes in patients treated for hypertension and left ventricular hypertrophy: the LIFE study. J Intern Med (2007) 0.92
Increased platelet catecholamine content in pheochromocytoma: a diagnostic test in patients with elevated plasma catecholamines. N Engl J Med (1982) 0.92
Hypertension optimal treatment (HOT) study: home blood pressure in treated hypertensive subjects. Hypertension (1998) 0.91
Genetic contribution to the variance in left ventricular mass: the Tecumseh Offspring Study. J Hypertens (2001) 0.91
Sympathetics, insulin resistance and coronary risk in hypertension: the 'chicken-and-egg' question. J Hypertens (1994) 0.90
Vasoconstriction with norepinephrine causes less forearm insulin resistance than a reflex sympathetic vasoconstriction. Hypertension (1994) 0.90
Disease entities, mixed multi-normal distributions, and the role of the hyperkinetic state in the pathogenesis of hypertension. Stat Med (1990) 0.89
Stroke volume--pulse pressure relationships in borderline hypertension: a possible indicator of decreased arterial compliance. J Hypertens Suppl (1984) 0.89
Relationship of age and blood pressure to baroreflex sensitivity and arterial compliance in man. Clin Sci Mol Med Suppl (1976) 0.89
Home blood pressure monitoring. Current knowledge and directions for future research. Blood Press (2001) 0.89
Regression of electrocardiographic left ventricular hypertrophy predicts regression of echocardiographic left ventricular mass: the LIFE study. J Hum Hypertens (2004) 0.89
Altered cardiac responsiveness and regulation in the normal cardiac output type of borderlind hlpertension. Circ Res (1975) 0.88
Stroke is more common than myocardial infarction in hypertension: analysis based on 11 major randomized intervention trials. Blood Press (2001) 0.88
University of California, Davis, conference: Mild hypertension. Am J Med (1988) 0.87
Determinants of baroreflex sensitivity in man. J Lab Clin Med (1978) 0.87
Pharmacologic reduction of sympathetic drive increases platelet alpha-2-receptor number. Clin Pharmacol Ther (1985) 0.87
Usefulness of home BP determination in treating borderline hypertension. JAMA (1982) 0.86
Abnormalities of plasma volume in borderline hypertension. Arch Intern Med (1971) 0.86
Reflex-hemodynamic adjustments and baroreflex sensitivity during converting enzyme inhibition with MK-421 in normal humans. Hypertension (1983) 0.85
Role of cardiac factors in the initial hypotensive action by beta-adrenoreceptor blocking agents. Hypertension (1984) 0.85
Effect of circulating epinephrine on platelet function and hematocrit. Hypertension (1995) 0.85
Syndrome X: is it for real? Genet Epidemiol (1998) 0.85
Home blood pressure as a predictor of future blood pressure stability in borderline hypertension. The Tecumseh Study. Am J Hypertens (1997) 0.85
Relation of renin status to neurogenic vascular resistance in borderline hypertension. Am J Cardiol (1975) 0.85
Evidence against an interaction of angiotensin II with the sympathetic nervous system in man. Clin Endocrinol (Oxf) (1981) 0.85
Relevance of heart rate as a risk factor in hypertension. Curr Hypertens Rep (1999) 0.85
The physiological determinants and risk correlations of elevated heart rate. Am J Hypertens (1999) 0.85
Suppression of sympathetic nervous function in low-renin essential hypertension. Lancet (1976) 0.84
Hematocrit levels and physiologic factors in relationship to cardiovascular risk in Tecumseh, Michigan. J Hypertens (1994) 0.84
Hemodynamic effects of angiotensin-converting enzyme inhibitors in essential hypertension: a review. J Cardiovasc Pharmacol (1985) 0.84
Plasma norepinephrine variations with dietary sodium intake. Hypertension (1980) 0.83
Heritability of left atrial size in the Tecumseh population. Eur J Clin Invest (2002) 0.83
The role of the autonomic nervous system in hypertension. Hypertens Res (1995) 0.83
3D.01: VISIT-TO-VISIT BLOOD PRESSURE VARIABILITY INCREASES RISK OF STROKE OR CARDIAC EVENTS IN PATIENTS GIVEN VALSARTAN OR AMLODIPINE IN THE VALUE TRIAL. J Hypertens (2015) 0.83
Anger and anxiety in borderline hypertension. Psychosom Med (1986) 0.83
Treatment of mild hypertension with progressive muscle relaxation. Predictive value of indexes of sympathetic tone. Arch Intern Med (1984) 0.82
Anxiety and cardiovascular reactivity in the Tecumseh population. J Hypertens (1998) 0.82
Agreement among three different indices of sympathetic nervous system activity in essential hypertension. Mayo Clin Proc (1977) 0.81
Role of central blood volume in hyperkinetic borderline hypertension. Br Heart J (1973) 0.81
Predictors of hypertension. Ann N Y Acad Sci (1978) 0.81
Lowering of blood pressure and predictors of response in patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint. Am J Hypertens (2000) 0.80
Effect of systemic autonomic inhibition on the hemodynamic response to antihypertensive therapy with timolol. Int J Clin Pharmacol Biopharm (1979) 0.80
Smoking is associated with higher cardiovascular risk in young women than in men: the Tecumseh Blood Pressure Study. J Hypertens (1997) 0.80
Systemic haemodynamics in borderline arterial hypertension: responses to static exercise before and under the influence of propranolol. Cardiovasc Res (1972) 0.80
The determinants of plasma-renin activity in essential hypertension. Ann Intern Med (1978) 0.80
Linkage of MN locus and erythrocyte lithium-sodium countertransport in Tecumseh, Michigan. Hypertension (1991) 0.80
Hemodynamics of prehypertension and hypertension. Verh Dtsch Ges Inn Med (1974) 0.80
Effects of increased arterial epinephrine on insulin, glucose and phosphate. Blood Press (1996) 0.79
Vasodilators in the treatment of hypertension. Compr Ther (1982) 0.79
The Tecumseh Blood Pressure Study. Normative data on blood pressure self-determination. Arch Intern Med (1990) 0.79
Red blood cell lithium-sodium countertransport in the tecumseh blood pressure study. Hypertension (1991) 0.79
New markers for type A behavior: pupil size and platelet epinephrine. Psychosom Med (1988) 0.79
The effect of hypertensive episodes and cardiac hypertrophy on the canine cardiac baroreflex. Clin Exp Pharmacol Physiol (1994) 0.79
Behavior, blood pressure variability, and hypertension. Psychosom Med (1985) 0.78
Characteristics of 15,314 hypertensive patients at high coronary risk. The VALUE trial. The Valsartan Antihypertensive Long-term Use Evaluation. Blood Press (2001) 0.78
Stress, autonomic hyperactivity and essential hypertension: an enigma. J Hypertens Suppl (1985) 0.78
Clinical and physiological significance of borderline hypertension at youth. Pediatr Clin North Am (1978) 0.78